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GENETICS OF IMMUNITY
Aberrant Activation of p38 MAP Kinase-Dependent
Innate Immune Responses Is Toxic to
Caenorhabditis elegans
Hilary K. Cheesman,*,1 Rhonda L. Feinbaum,†,1 Jose Thekkiniath,* Robert H. Dowen,† Annie L. Conery,†
and Read Pukkila-Worley*,2
*Program in Innate Immunity, Division of Infectious Diseases and Immunology, University of Massachusetts Medical
School, Worcester, Massachusetts 01605, and †Department of Molecular Biology, Massachusetts General Hospital,
Boston, Massachusetts 02114
ABSTRACT Inappropriate activation of innate immune responses in intestinal epithelial cells underlies the
pathophysiology of inﬂammatory disorders of the intestine. Here we examine the physiological effects of
immune hyperactivation in the intestine of the nematode Caenorhabditis elegans. We previously identiﬁed an
immunostimulatory xenobiotic that protects C. elegans from bacterial infection by inducing immune effector
expression via the conserved p38 MAP kinase pathway, but was toxic to nematodes developing in the
absence of pathogen. To investigate a possible connection between the toxicity and immunostimulatory
properties of this xenobiotic, we conducted a forward genetic screen for C. elegans mutants that are resistant
to the deleterious effects of the compound, and identiﬁed ﬁve toxicity suppressors. These strains contained
hypomorphic mutations in each of the known components of the p38 MAP kinase cassette (tir-1, nsy-1, sek-1,
and pmk-1), demonstrating that hyperstimulation of the p38 MAPK pathway is toxic to animals. To explore
mechanisms of immune pathway regulation in C. elegans, we conducted another genetic screen for dominant
activators of the p38 MAPK pathway, and identiﬁed a single allele that had a gain-of-function (gf) mutation in
nsy-1, the MAP kinase kinase kinase that acts upstream of p38 MAPK pmk-1. The nsy-1(gf) allele caused
hyperinduction of p38 MAPK PMK-1-dependent immune effectors, had greater levels of phosphorylated p38
MAPK, and was more resistant to killing by the bacterial pathogen Pseudomonas aeruginosa compared to
wild-type controls. In addition, the nsy-1(gf) mutation was toxic to developing animals. Together, these data
suggest that the activity of the MAPKKK NSY-1 is tightly regulated as part of a physiological mechanism to
control p38 MAPK-mediated innate immune hyperactivation, and ensure cellular homeostasis in C. elegans.
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Coordination of innate immune responses at mucosal surfaces is a
critical determinant of cellular homeostasis in evolutionarily diverse
organisms (Peterson and Artis 2014). Exaggerated or aberrantly
triggered immune responses, for example, underlie the pathophysi-
ology of inﬂammatory disorders of the human intestine (Xavier and
Podolsky 2007). In ﬂies, immune pathway hyperactivation also has
negative physiological consequences and is subject to feedback control
(Aggarwal and Silverman 2008).
To understand ancient mechanisms of pathogen detection and
immune regulation,ourgroupandothers are examining innate immune
responses in the nematodeCaenorhabditis elegans (Irazoqui et al. 2010;
Pukkila-Worley and Ausubel 2012; Cohen and Troemel 2015). As in
other metazoans, nematodes coordinate inducible immune defenses
from intestinal epithelial cells (IECs), which provide a critical barrier
against ingested pathogens (Kim et al. 2002; Shivers et al. 2009;
Pukkila-Worley et al. 2011). Studies from C. elegans and other diverse
organisms have revealed that key innate immune signaling regulators
are strongly conserved (Irazoqui et al. 2010; Pukkila-Worley and
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Ausubel 2012; Visvikis et al. 2014; Cohen and Troemel 2015). For
example, the NSY-1-SEK-1-PMK-1 Mitogen Activated Protein Ki-
nase (MAPK) pathway in C. elegans, which is orthologous to the
mammalian ASK1-MKK3/6-p38 MAPK pathway, controls the in-
duction of putative antimicrobial immune effectors, and is required
in intestinal epithelial cells for nematodes to survive challenge from
ingested pathogens (Kim et al. 2002; Troemel et al. 2006; Shivers et al.
2010; Pukkila-Worley et al. 2011). In mammals, the ASK1-MKK3/
6-p38 signaling cassette is a central regulator of inﬂammatory cyto-
kine production in response to pathogen detection at epithelial sur-
faces, and pathway activation is tightly regulated through negative
regulatory circuits (Kyriakis and Avruch 2012). Misregulation of
p38 signaling in IECs has been implicated in the pathogenesis of
inﬂammatory bowel disease, cancer, autoimmune disorders, and im-
munodeﬁciency syndromes (Waetzig et al. 2002; Kyriakis and Avruch
2012). From an evolutionary perspective, it is therefore logical that
mechanisms of immune homeostasis are selected for as part of a
survival strategy, particularly for organisms such as bacterivorous
nematodes that live in microbe-rich environments and must distin-
guish pathogens from potential food sources.
Here we focus on the p38 MAPK pathway in C. elegans,
and examine the physiological consequences of innate immune
hyperactivation in intestinal epithelial cells. From two different
forward genetic screens, we present evidence that aberrant activa-
tion of p38 MAPK-mediated defenses in intestinal epithelial cells is
deleterious to nematodes. We found that the toxicity associated
with exogenous stimulation of the p38 MAPK-mediated immune
responses can be suppressed through loss-of-function mutations in
p38 MAPK pathway components. We also identify and character-
ize a gain-of-function allele of the MAPKKK nsy-1 that drives
hyperactivation of the p38 MAPK PMK-1 pathway. Accordingly,
the nsy-1(gf) allele is protective against bacterial infection, but the
concomitant hyperactivation of innate immune effectors is dele-
terious to developing animals. These data suggest that the MAPKKK
NSY-1 is negatively regulated as a part of mechanism to ensure
immune homeostasis.
MATERIALS AND METHODS
C. elegans and bacterial strains
C. elegans was grown and propagated on NGM plates with Escherichia
coli OP50, as described (Brenner 1974). AU307, an N2 Bristol-derived
strain carrying the agIs44 transgene (pF08G5.6::GFP::unc-54-39UTR;
pmyo-2::mCherry), which was outcrossed to the wild-type strain N2
ﬁve times (Pukkila-Worley et al. 2014), was used as the wild-type strain
for these studies, unless otherwise noted. N2 was used as the wild-type
strain for the studies presented in Figure 1. Previously isolated and
characterized mutants used in this study were: nsy-1(ag3) II (Kim
et al. 2002), tir-1(qd4) III (Shivers et al. 2009), xbp-1(zc12) III; zcIs4
V (Calfon et al. 2002), pmk-1(km25) IV (Kim et al. 2002), and zcIs4 V
(Calfon et al. 2002). RPW1 nsy-1(ums1) II, RPW2 tir-1(ums2) III,
RPW3 tir-1(ums3) III, RPW4 pmk-1(ums4) IV, and RPW5 sek-1
(ums5) Xwere isolated in this study as described below. RPW43 agIs44;
nsy-1(ums8) was also isolated in this study as described below, and
outcrossed six times to the wild-type strain N2.
Isolation and identiﬁcation of mutants with an
Xts phenotype
Mutagenesis of wild-type N2 animals was performed with ethyl meth-
ane sulfonate (EMS, Sigma-Aldrich Co.) following standard methods
(Jorgensen and Mango 2002). In two separate rounds of EMS
Figure 1 p38 MAPK mutants have a Xenobiotic toxicity suppressor
(Xts) phenotype. (A) Representative images of C. elegansmutants with
an Xts phenotype photographed after 3 d of development at 20C in
the presence (+) or absence (–) of 140 mM R24. C. elegans N2 animals
were used as the wild-type control strain. (B) Quantiﬁcation of the
percentage of animals that grew from the L1 to young adult (YA) stage
for the experiment shown in (A). Data are the average of two technical
replicates, with error bars giving the standard deviation between
plates. The sample sizes for this experiment are: N2 (196), nsy-1(ums1)
(171), tir-1(ums2) (193), tir-1(ums3) (220), pmk-1(ums4) (145), sek-1(ums5)
(196), pmk-1(km25) (155), tir-1(qd4) (269) and nsy-1(ag3) (193).  P ,
0.05,  P = 0.07. The data are representative of multiple biological
replicate experiments, which were conducted during the backcrossing
of the ums mutants to wild-type animals. (C) A P. aeruginosa patho-
genesis assay with C. elegans wild-type N2 and mutants with an Xts
phenotype is shown. The difference in P. aeruginosa susceptibility
between all mutants with an Xts phenotype and wild-type animals is
signiﬁcant (P , 0.001), except nsy-1(ums1) (P = n.s.). Sample sizes are:
wild-type N2 (152), nsy-1(ums1) (140), tir-1(ums2) (151), tir-1(ums3)
(150), pmk-1(ums4) (124), and sek-1(ums5) (139). (D) Immunoblot anal-
ysis of lysates from L4 larval stage animals of the indicated genotype
using antibodies that recognize the doubly phosphorylated TGY motif
of PMK-1 (p-PMK-1) and actin.
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screening, F2 animals from approximately 100,000 mutagenized
haploid genomes were synchronized by hypochlorite treatment,
and plated onto “slow kill” media (Tan et al. 1999) containing
140 mM of R24. We previously used 70 mM for our characterization
of R24 immunostimulatory properties (Pukkila-Worley et al. 2012).
The lower concentration also delayed the development of wild-type
nematodes, but the phenotype was more pronounced at a concen-
tration of 140 mM. Animals that reached at least the L4 larval stage
after approximately 60 hr at 20 were singled to a new plate. Of the
unmutagenized animals treated in parallel, 100% were at the L2 or
L3 larval stage at this time point. Five mutants with the most pen-
etrant Xts phenotypes after three rounds of retesting were identiﬁed
using next-generation sequencing technology (Illumina, Inc.) fol-
lowing established methods (Sarin et al. 2008). Brieﬂy, the progeny
from individual F2 recombinant animals that had the mutant phe-
notype following a 1X backcross to N2 animals were pooled for
ums3, ums4, and ums5 (40, 38, and 33 pooled recombinants, respec-
tively). DNA was isolated from these samples, and from the original
ums1 and ums2 mutants, using the Gentra Puregene Kit (Qiagen).
Libraries for deep sequencing were prepared using the NEBNext
DNA Library Prep Reagent Set and Oligos (New England Biolabs,
Inc.), and sequenced using Illumina HiSeq 2500 following instruc-
tions from the manufacturer. Homozygous variants from the
WS220 (ce10) C. elegans reference genome were identiﬁed using
CloudMap (Minevich et al. 2012), and removed from further anal-
ysis if they were present in the unmutagenized parent wild-type
N2 strain, the genome of which was also sequenced.
Isolation and identiﬁcation of a constitutive activator
of F08G5.6::GFP
EMS mutagenesis was performed on strain agIs44 as described above.
Synchronized F1 progeny from approximately 170,000 mutagenized
haploid genomes were screened for animals that constitutively express
agIs44 GFP (green ﬂuorescent protein) ﬂuorescence using a dissecting
microscope that is able to visualize GFP. A single mutant allele, ums8,
was identiﬁed. To identify the ums8 mutation, DNA was isolated and
sequenced using the methods described above. Pools of progeny from a
total of 52 individual recombinants from a single outcross to wild-type
N2, and from 43 individual recombinants that were outcrossed
twice to N2, were sequenced. All recombinants selected for sequenc-
ing expressed agIs44 GFP ﬂuorescence constitutively. Homozygous
variants from the WS220 (ce10) C. elegans reference genome that
were present in both the 1X and 2X backcross samples, but were
not present in the parent agIs44 strain, were identiﬁed using
CloudMap (Minevich et al. 2012).
RNAi of nsy-1
Two RNAi constructs were created using 731 bp and 1007 bp
segments of nsy-1 coding region (bases 32,533 to 33,264, and
30,950 to 31,957 on cosmid F59A6, respectively), which were am-
pliﬁed by PCR and subcloned into the Fire vector pPD129.36, liga-
tion number L4440 (referred to throughout the manuscript as
L4440) to create plasmids pHC1 and pHC2, respectively. These
plasmids were transformed into the RNAi bacterial feeder strain
HT115, and RNAi experiments were carried out with these strains
following established protocols (Timmons et al. 2001) using HT115
bacteria expressing the empty vector L4440 as the control. For all
RNAi experiments, L4 larval stage animals of the indicated geno-
types were picked to RNAi bacteria, and F1 progeny were used for
subsequent studies, as described in more detail below.
nanoString nCounter gene expression and quantitative
RT-PCR (qRT-PCR)
For the nanoString transcription proﬁling experiment, hypochlorite-
synchronized L1 larval stage animals were added to NGMplates seeded
with OP50. nsy-1(ums8) mutant animals were added to these plates
approximately 24 hr before the nsy-1(ag3) and agIs44 animals, to allow
the animals to reach the L4 larval stage at the time of harvest. The
agIs44 animals were used as the wild-type control for this experiment.
Worms were ﬂash-frozen in an ethanol and dry ice bath, lysed in 0.5%
SDS, 5% b-mercaptoethanol, 10 mM EDTA, 10 mMTris-HCl pH 7.4.,
0.5 mg/ml Proteinase K at 55 for 15 min using a previously described
protocol (Ding et al. 2015), RNA was isolated using Tri-reagent
(Sigma-Aldrich Co.), and 100 ng was analyzed by the nanoString
nCounter Gene Expression System (nanoString Technologies, Inc.)
using a “codeset” designed by nanoString that contained probes for
118C. elegans genes (Supporting Information, Table S1). Probe hybrid-
ization, data acquisition and analysis were performed according to
instructions from nanoString with the expression data from each sam-
ple normalized to the geometric mean of expression values for the
control genes snb-1, ama-1, and act-1.
To determine the gene induction in nsy-1(ums8)/+ heterozygotes,
RNA was isolated from 100 L4 larval stage agIs44 (+/+), nsy-1
(ums8)/nsy-1(ums8) homozygotes, and nsy-1(ums8)/+ heterozy-
gotes, the latter of which were the F1 progeny from a cross between
agIs44 animals and nsy-1(ums8) homozygotes. RNA was isolated
from three replicates using Trizol (Sigma-Aldrich Co.), treated with
recombinant DNaseI (Ambion), reverse transcribed to cDNA using
the Retro-script kit (Life Technologies), and analyzed using iQ
SYBR Green detection (Bio-Rad Laboratories, Inc.) in duplicate
20-ml reactions on a CFX1000 machine (Bio-Rad Laboratories,
Inc.) with previously published primers (Troemel et al. 2006;
Pukkila-Worley et al. 2012). All values were normalized against
the control gene snb-1. Fold change was calculated using the Pfafﬂ
method (Pfafﬂ 2001). For the other qRT-PCR studies, four L4 larval
stage animals of the indicated genotype were added to RNAi bacte-
ria, and RNA was harvested from the mixed-stage F1 progeny from
these animals. To ensure that animals would be approximately
stage-matched at the time of harvest, nsy-1(ums8) mutants were
allowed to lay their brood and develop at 20, while agIs44 and
nsy-1(ag3) animals were kept at 15. RNA was isolated from three
replicates using Tri-reagent (Sigma-Aldrich Co.), reversed tran-
scribed into cDNA, and studied by qRT-PCR following the protocol
described above.
Immunoblot analyses
C. elegans was prepared in the manner described for the nanoString
experiment to ensure that stage-matched animals at the young L4 larval
stage were studied in each condition. A previously described protocol
(Ding et al. 2015) was adapted for the immunoblot analysis. Harvested
animals were washed twice with M9 buffer, incubated in a roller at
room temperature for 15min to allow the nematode intestine to clear of
bacteria, washed an additional time and ﬂash-frozen in RIPA Buffer
(Cell Signaling Technology, Inc.) using an ethanol and dry ice bath.
Samples were lysed by sonication and centrifuged. Protein was quan-
tiﬁed from the supernatant of each sample using Bradford Reagent
(Bio-Rad Laboratories, Inc.). Laemmli buffer (Bio-Rad Laboratories,
Inc.) was added to a concentration of 1X, and the total protein from
each sample was resolved on NuPage 4–12% gels (Life Technologies),
transferred to nitrocellulose membranes (Life Technologies), blocked
with 5% powdered milk in TBST, and probed with a 1:2000 dilution of
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an antibody that recognizes the doubly phosphorylated TGY motif
of PMK-1 (Promega Corporation). The blot was then stripped and
reprobed with a 1:10,000 dilution of an anti-actin antibody (Thermo
Fisher Scientiﬁc, Inc.). Horseradish peroxidase (HRP)-conjugated
anti-rabbit, and anti-mouse IgG secondary antibodies (Thermo
Fisher Scientiﬁc, Inc.) were used to detect the primary antibodies
following the addition of ECL reagents (Thermo Fisher Scientiﬁc,
Inc.), which were visualized using a Fujiﬁlm LAS-400 luminescent
image analyzer.
C. elegans bacterial infection and development assays
“Slow killing” P. aeruginosa infection assays were performed as previ-
ously described (Tan et al. 1999). A single colony of P. aeruginosa PA14
was inoculated into 3 ml of Luria-Bertani (LB) medium, and allowed
to incubate at 37 for 14–15 hr; 10 ml of this culture was added to
35-mm tissue culture plates containing 4 ml of slow kill agar (0.35%
peptone, 0.3% sodium chloride, 1.7% agar, 5 mg/ml cholesterol, 25 mM
potassium phosphate, 1 mM magnesium sulfate, 1 mM calcium chlo-
ride). Plates were incubated for 24 hr at 37, and 24 hr at 25. At 1–2 hr
before the start of the assay, 0.1 mg/ml 5-ﬂuorodeoxyuridine (FUDR)
was added to the medium to prevent progeny from hatching. A total of
40–50 animals at the young L4 larval stage were picked to each of three
or four assay plates per experimental condition.C. eleganswas prepared
for the pathogenesis assays in the manner described above for the
nanoString experiment to ensure that stage-matched nematodes were
used for these experiments. Animals were scored as live or dead on a
daily basis by gently touching them with a platinum wire. Worms that
crawled onto the wall of the tissue culture plate were eliminated from
the analysis. P. aeruginosa killing assays were conducted at 25.
The development assay presented in Figure 1 was conducted by
placing approximately 100 hypochlorite-synchronized L1 larval stage
animals of the indicated genotype on “slow kill” medium plates (Tan
et al. 1999) containing 140 mMR24 or the solvent control DMSO (1%),
and monitoring development to the young adult stage for 3 d at 20
on two replicate plates per condition. For the development assays
conducted with RNAi bacteria (Figure 4B), two L4 larval stage animals
of the indicated genotype were allowed to lay their brood on RNAi
bacteria at 15. Plates were then transferred to 20 for 3 d. The stage
of approximately 300 animals on each of three replicate plates per con-
dition was recorded, and the percentage of animals at the L4 larval stage
was reported. Representative animals from each condition in this exper-
iment were photographed. For the experiments with the xbp-1(zc12)
mutant (Figure S4), four animals were allowed to lay their brood for
8 hr at 20 in the presence or absence of 70mMR24. C. elegans carrying
the zcIs4 transgene was used as the control for these experiments.
Microscopy
Nematodesweremountedonto 2%agar pads, paralyzedwith levamisole
(Sigma-Aldrich Co.), and photographed using a AXIO Imager Z1
microscope with a AxioCamHRm camera and Axiovision 4.6 software
(Zeiss), or an Eclipse E400 with a DS-QilMc camera and NIS Elements
Imaging Software (Nikon Corporation). Photographs were acquired
using the same imaging conditions for a given experiment, and were
processed in Photoshop (Adobe Systems, Inc.).
Statistical analyses and amino acid alignment
Differences in survival of C. elegans animals in the P. aeruginosa patho-
genesis assays were determined with the log-rank test. Fold changes in the
qRT-PCR analyses and differences in the development of animals to the
indicated stage were compared using unpaired, two-tailed student t-tests.
Amino acid alignment between human ASK1, theDrosophila Pk92B, and
C. elegans NSY-1, was determined using ClustalW2 (Larkin et al. 2007).
Data availability
Strains are available upon request. Accession numbers for genes and
gene products are given for the publically available databaseWormbase
(http://www.wormbase.org). The accession numbers for the principal
genes mentioned in this paper are: C17H12.8, C32H11.12, F08G5.6,
F35E12.5, F56D6.2, nsy-1 (F59A6.1), pmk-1 (B0218.3), sek-1 (R03G5.2),
tir-1(F13B10.1), T24B8.5. Other accession numbers are given in
Table S1.
RESULTS AND DISCUSSION
Exogenous hyperactivation of the p38 MAP kinase
pathway is toxic to developing C. elegans
The small molecule R24, also called RPW-24, acts upstream of the
p38 MAPK pathway to cause the induction of putative antibacterial
immune effectors in the intestine of C. elegans and, accordingly,
protects nematodes from bacterial infection (Pukkila-Worley et al.
2012, 2014). In addition, exposure to R24 causes the induction of
detoxiﬁcation enzymes and delays the development of wild-type
nematodes in the absence of pathogen, suggesting that this com-
pound is toxic to C. elegans under normal laboratory growth
conditions (Pukkila-Worley et al. 2012, 2014). To investigate the
relationship between the immunostimulatory properties and the
toxicity of this anti-infective xenobiotic, we screened nematodes
derived from approximately 100,000 mutagenized haploid genomes
for mutants that were able to develop faster in the presence of
140 mM R24 (Figure 1, A and B). We chose this concentration
because the developmental delay phenotype was more pronounced
than observed for 70 mM R24, the concentration we had used in our
previous studies (Pukkila-Worley et al. 2012, 2014). For the screen,
we required the selected mutants to be L4 larval stage or older at a
time point when 100% of unmutagenized worms treated with R24 in
parallel were at the L2 or L3 larval stage. Seven mutants with a
xenobiotic toxicity suppressor (Xts) phenotype were identiﬁed,
and we focused on the ﬁve mutants that had the most penetrant
Xts phenotypes which we have called ums1, ums2, ums3, ums4 and
ums5 (Figure 1, A and B). To identify the mutation in these strains
that permitted improved development in the presence of R24, we
used next-generation sequencing technology (Sarin et al. 2008;
Minevich et al. 2012). For three mutants (ums3, ums4, and ums5),
we sequenced DNA from pooled F2 recombinants that had the
mutant phenotype following a backcross to wild-type N2 animals,
and for two mutants (ums1 and ums2) we identiﬁed mutations after
sequencing the original mutant strain. Interestingly, these ﬁve
n Table 1 Xenobiotic toxicity suppressors
Gene Allele Mutation
Description, Mammalian
Homolog
tir-1 ums2 L730F TIR domain adaptor
protein, SARM
tir-1 ums3 A723T TIR domain adaptor
protein, SARM
nsy-1 ums1 P874L MAPKKK, ASK1
sek-1 ums5 G199S MAPKK, MKK3/6
pmk-1 ums4 L296F MAPK, p38
Presented is a list of isolates identiﬁed in a screen for mutants that are able to
develop faster in the presence of the immunostimulatory anti-infective xenobi-
otic R24 compared to controls.
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mutants each contained missense mutations in one of the four
known components of the p38 MAPK signaling cassette (tir-1, nsy-1,
sek-1, or pmk-1, Table 1).
To characterize these newly-isolated p38 MAPK pathway
mutants, we conducted pathogenesis assays with P. aeruginosa
and found that, as with the classic loss-of-function mutants in p38
MAPK pathway components, four of the ﬁve mutants [tir-1(ums2),
tir-1(ums3), pmk-1(ums4) and sek-1(ums5)] had an enhanced sus-
ceptibility to pathogens (Esp) phenotype (P , 0.001, Figure 1C).
nsy-1(ums1), the weakest toxicity suppressor of these ﬁve mutants,
did not have an obvious Esp phenotype. In addition to conferring an
Esp phenotype, loss- and reduction-of-function mutations in up-
stream components of the p38 MAPK PMK-1 pathway cause a re-
duction in the amount of activated PMK-1, which can be detected in
an immunoblot experiment using an antibody that speciﬁcally rec-
ognizes the doubly phosphorylated TGYmotif of PMK-1 (Kim et al.
2002; Liberati et al. 2004). We found that nsy-1(ums1), tir-1(ums2),
tir-1(ums3), pmk-1(ums4) and sek-1(ums5) each had reduced levels
of the active form of PMK-1 compared to wild-type controls (Figure
1D). These data indicate that the forward genetic screen formutations
that confer resistance to the toxic effects of the immunostimulatory
xenobiotic R24 identiﬁed hypomorphic alleles in the p38 MAPK
pathway. Interestingly, a previous forward genetic screen for loss-
of-function mutations in the p38 MAPK pathway components
identiﬁed two alleles, pmk-1(qd9) and sek-1(qd37), which had the
identical missense mutation as pmk-1(ums4) and at the same amino
acid as sek-1(ums5), respectively (Shivers et al. 2010).
Together, these data demonstrate that the toxicity of R24 can be
suppressed by hypomorphic mutations in the p38 MAPK pathway,
although no single mutation was identiﬁed that resulted in growth
progression identical to worms in the absence of the compound. To
conﬁrm this observation, we studied the previously characterized null
alleles tir-1(qd4), nsy-1(ag3) and pmk-1(km25) (Kim et al. 2002; Shivers
et al. 2009) (Figure 1, A and B) and found that these mutations also
suppressed the R24-induced developmental delay to a degree compa-
rable to the pmk-1(ums4)mutant, and the tir-1(ums2) and tir-1(ums3)
alleles, respectively (Figure 1, A and B).
In summary, these data indicate that hyperactivation of p38 MAPK
immune defenses is toxic to developing nematodes.
Forward genetic screen uncovers a gain-of-function
allele in the MAPKKK nsy-1
To explore further the physiological consequences of innate immune
hyperactivation in C. elegans, we designed a forward genetic screen for
endogenous activators of p38MAPkinase PMK-1 signaling. The innate
immune transcriptional reporter F08G5.6::GFP is induced during
P. aeruginosa infection, and robustly by the anti-infective xenobiotic
R24, in a manner dependent on the p38 MAPK PMK-1 pathway
(Pukkila-Worley et al. 2012, 2014).We therefore reasoned that a screen
for dominant activators of F08G5.6::GFPwould identify mutations that
cause constitutive activation of the p38 MAPK pathway. We screened
the F1 progeny of mutagenized F08G5.6::GFP animals, and iden-
tiﬁed a single mutant allele, ums8, from approximately 170,000
mutagenized haploid genomes. Following both 1X and 2X outcrosses
Figure 2 The nsy-1(ums8) allele encodes a gain-of-
function mutation in nsy-1. (A) The putative domain
architecture of NSY-1, based on homology to mamma-
lian ASK1, is presented. This schematic was adapted
from Bunkoczi et al. (2007). The putative location of
the central serine-threonine kinase domain, and two
coiled-coil domains in the N and C termini are shown
in red and blue, respectively. The boundary of the
N-terminal negative regulatory domain relative to
the NSY-1 protein is presented above the diagram.
The Arg that was mutated to Gln in the ums8 strain
(R246Q) is highlighted in red. Amino acid sequence
alignment of human ASK1, Drosophila Pk92B (the
ASK1 homolog) and C. elegans NSY-1 demonstrates
that the ums8 mutation is located in a strongly con-
served region. Dark blue shading indicates identical
amino acids, with progressive lighter blue shading
indicating the level of similarity in amino acid class
as determined by the software ClustalW2. (B) Wild-type
(WT) and nsy-1(ums8) animals were exposed to the
feeding RNAi bacteria strain transformed with the
control vector (L4440), or with two separate RNAi
constructs (pHC1 and pHC2) that target different
areas of coding region in the nsy-1 gene and
photographed. Green is F08G5.6::GFP induction and red is myo-2::mCherry, which was used as the co-injection marker. (C) The expression of
the indicated genes was determined using qRT-PCR in wild-type (+/+), nsy-1(ums8)/+ heterozygotes, and nsy-1(ums8)/nsy-1(ums8) homozygotes.
F08G5.6::GFP was used as the wild-type strain. Data are the average of three replicates, each normalized to a control gene with error bars
representing SEM, and are presented as the value relative to the average expression of the indicated gene in wild-type animals.  equals P, 0.05.
There was no statistical difference in the levels of induction between the heterozygous and homozygous samples for either gene. For additional
genes tested, see Figure S1A. (D) Immunoblot analysis of lysates from L4 larval stage animals of the indicated genotype using antibodies that
recognize the doubly phosphorylated TGY motif of PMK-1 (p-PMK-1) and actin. Thirty mg of nsy-1(ums8), pmk-1(km25) and nsy-1(ag3) total
protein were loaded on the gel alongside a dilution series of wild-type template [15 mg, 20 mg, and 30 mg of total protein (left to right)] to control
for the ability of the p-PMK-1 antibody to detect different concentrations of substrate. The arrow on the right highlights the PMK-1 band, which is
absent in the pmk-1(km25) and nsy-1(ag3) mutants. The arrowheads on the left point to nonspeciﬁc bands. Data are representative of two
biological replicates.
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to wild-type N2 animals, we pooled F2 recombinants that were ho-
mozygous for the mutant phenotype, and sequenced the genomes of
these samples using next-generation sequencing technology (Sarin
et al. 2008; Minevich et al. 2012). This study revealed that the ums8
mutant contained a G/Amissense mutation in the coding region of
nsy-1 that resulted in the substitution of a strongly conserved Arg246
to Gln246 (Figure 2A). NSY-1/ASK1 is a conserved MAPKKK that
acts upstream of the p38 MAPK PMK-1 to regulate immune and
stress responses in C. elegans (Kim et al. 2002). We outcrossed the
ums8 strain a total of six times to wild-type N2, and conﬁrmed that
the R246Q mutation was present and F08G5.6::GFP expression was
activated in the outcrossed strain.
To determine if the constitutive expression of the immune reporter
F08G5.6::GFP in the ums8mutant is caused by the G/A mutation in
the coding region of nsy-1, we used RNAi to knockdown the expression
of nsy-1 in the ums8 mutant and found that this treatment suppressed
F08G5.6::GFP induction (Figure 2B). Moreover, RNAi-mediated
knockdown of nsy-1 in wild-type animals did not cause F08G5.6 in-
duction (see qRT PCR data discussed in the next section). In addition,
F08G5.6::GFP induction in the nsy-1(ums8) strain was suppressed by
RNAi-mediated knockdown of pmk-1, the p38 MAPK that is down-
stream of nsy-1 (Figure S2A). We also used qRT-PCR to conﬁrm that
nsy-1(ums8) is a dominant, gain-of-function allele that drives both the
constitutive activation of the F08G5.6::GFP and the F08G5.6 gene
itself (Figure 2C). F08G5.6 and GFP were induced to a similar degree
in nsy-1(ums8)/+ heterozygotes and in nsy-1(ums8)/nsy-1(ums8) ho-
mozygotes compared to wild-type controls that carried the transgene
F08G5.6::GFP (+/+).
Consistent with our studies suggesting that nsy-1(ums8) is a gain-of-
function allele of nsy-1, we performed an immunoblot analysis of pro-
tein lysates from nsy-1(ums8) animals and found that the nsy-1(ums8)
animals had greater amounts of activated p38 MAPK PMK-1 than
control animals (Figure 2D).
In summary, these data characterize a gain-of-function allele of
the MAPKKK nsy-1 that causes hyperactivation of the p38 MAPK
pathway.
The nsy-1(ums8) gain-of-function allele causes the
constitutive activation of p38 MAPK PMK-1-dependent
innate immune effectors
Todetermine if thebasal expressionof other geneswashyperactivated in
the nsy-1(ums8) allele, we used the nanoString nCounter system to
compare the expression proﬁle of 118 innate immune and stress re-
sponse genes in nsy-1(ums8) gain-of-function, nsy-1(ag3) loss-of-
function and wild-type animals when the strains were feeding on the
normal laboratory food source E. coli OP50 (Figure 3A). Of the
118 genes in this codeset, 24 were transcriptionally upregulated at least
ﬁvefold in nsy-1(ums8)mutants compared to wild-type animals (Table
S1). Seven of the 24 genesmost strongly upregulated in the nsy-1(ums8)
gain-of-function allele were among the 12 most strongly reduced in
the nsy-1(ag3) loss-of-function allele (F08G5.6, F35E12.5, C09H5.2,
T24B8.5, clec-67, C32H11.12, and oac-6, Figure 3A and Table S1). In-
deed, this group of seven genes includes F08G5.6 and ﬁve other putative
immune effectors (F35E12.5, C09H5.2, T24B8.5, C32H11.12 and
clec-67) that are previously characterized targets of the p38 MAPK
PMK-1 (Table S1) (Troemel et al. 2006). Of note, the codeset included
Figure 3 p38 MAPK-dependent putative immune
effectors are constitutively activated in the nsy-1
(ums8) mutant. (A) A scatter plot compares the ex-
pression of 118 C. elegans genes, which were an-
alyzed using nanoString nCounter gene expression
system in wild-type, nsy-1(ums8) and nsy-1(ag3) an-
imals. Data are the average of two replicates for
nsy-1(ums8), and nsy-1(ag3), and are from one sam-
ple for wild-type. The expression of each gene was
normalized to the geometric mean of the expres-
sion of three control genes. Genes that are outside
the two parallel lines on each graph are differen-
tially regulated more than ﬁvefold from the expres-
sion in wild-type animals. Genes that are previously
characterized targets of the p38 MAPK PMK-1, and
were strongly differentially regulated in this exper-
iment, are highlighted. See Table S1 for the ex-
pression levels of all the genes. (B) qRT-PCR was
used to study the expression of six putative im-
mune effectors in RNAi-treated, mixed-stage ani-
mals of the indicated genotypes. All animals were
grown on the RNAi bacteria feeder strain HT115
expressing the empty vector L4440, except for
the two indicated samples that were exposed to
bacteria expressing the nsy-1(RNAi) construct. The
location on the scatter plots of these genes is indi-
cated in (A) with red (left) and blue (right) dots. Data
are the average of three replicates, each normal-
ized to a control gene with error bars representing
SEM, and are presented as the value relative to
the average expression of the indicated gene in
wild-type animals.  equals P , 0.05.
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four additional genes whose basal or pathogen-induced expression
requires the p38 MAPK PMK-1 (F49F1.6, C17H12.8, C32H11.1,
K08D8.5, lys-2), and each of these genes was induced at least twofold
in the nsy-1(ums8)mutants, and repressed at least fourfold in the nsy-1
(ag3) mutants (Table S1). In addition, we previously used this codeset
to identify 13 genes whose induction by the immunostimulatory anti-
infective xenobiotic R24 was dependent on the p38 MAPK PMK-1
(Pukkila-Worley et al. 2014). Nine of these 13 genes were upregulated
more than ﬁvefold, and all of these genes were induced at least twofold
in the nsy-1(ums8) gain-of-function mutant (Table S1). Thus, the
nsy-1(ums8) gain-of-function allele drives the constitutive activation
of genes whose basal, pathogen-induced or R24-induced expression is
dependent the p38 MAPK pathway.
We conﬁrmed these data in three biological replicate samples using
qRT-PCR to study six putative immune effectors that were differentially
regulated in the nanoString analysis and are known targets of the p38
MAPK pathway. All six genes were transcriptionally repressed in
nsy-1(RNAi) and nsy-1(ag3) loss-of-function mutants, and were
upregulated in the nsy-1(ums8) allele (Figure 3B). RNAi-mediated
knockdown of nsy-1 partially suppressed the constitutive activation
of these six putative immune effectors in the nsy-1(ums8) allele
(Figure 3B). In addition, we found that nsy-1(ums8)/+ heterozygotes
caused the induction of three p38 MAPK-dependent immune effec-
tors to levels equivalent to that in nsy-1(ums8) homozygous animals
(Figure S1A), as we observed for F08G5.6 (Figure 2C). Of note, we also
exposed the nsy-1(ums8) mutant to R24, and found that F08G5.6::GFP
expression was markedly increased compared to untreated nsy-1(ums8)
animals, suggesting that the effects of R24 and the nsy-1 gain-of-function
allele on gene expression are additive (Figure S1B). Consistent with
this observation, we previously found that R24 also further enhanced
the expression of P. aeruginosa immune effectors that are induced
during bacterial infection (Pukkila-Worley et al. 2012).
Previous whole genome, transcriptome proﬁling analyses have
identiﬁed a group of putative immune effectors whose basal expression
is strongly repressed in pmk-1(km25) mutants (Troemel et al. 2006).
The term basal regulation has been used in this context to describe the
expression of genes in animals that are growing on the laboratory food
source (E. coli OP50) and is used to distinguish from the pathogen-
induced expression of putative immune effectors that is observed dur-
ing microbial infection. In addition to controlling the basal expression
of putative immune effectors, a number of studies have demonstrated
that the p38 MAPK PMK-1 is also required for the pathogen-induced
expression of putative immune effectors (Troemel et al. 2006; Bolz et al.
2010; Pukkila-Worley et al. 2012). It also is clear, however, that there is
a group of genes, the identities of which have not been comprehensively
deﬁned, that require the p38MAPK PMK-1 pathway for their induction,
but not for their basal expression. The nanoString data of nsy-1(ums8)
mutant indicates that this gain-of-function allele can be used to iden-
tify this group of innate immune effectors. Of the 24 genes in our
codeset that were most strongly induced in the nsy-1(ums8) mutant,
17 were not dependent on NSY-1 for their basal expression—a group
which includes both pathogen and stress-response genes (Table S1).
It is also interesting tonote thatgenes involved in thedetoxiﬁcationof
smallmolecule toxins, suchas cytochromeP450s (CYPs), glutathione-s-
transferases (GSTs), and UDP-glucuronosyltransferases (UDPs), were
not among those transcriptionally upregulated in the nsy-1(ums8) gain-
of-function allele (Table S1). We previously observed that the anti-
infective xenobiotic R24 caused the robust induction of these gene
classes, in addition to genes involved in the response to pathogens
(Pukkila-Worley et al. 2012). Unlike the induction of antimicrobial
immune effectors, however, the upregulation of detoxiﬁcation genes
by R24 was not dependent on the p38 MAPK PMK-1 pathway
(Pukkila-Worley et al. 2014). Together with the ﬁndings in this study,
these data argue that p38 MAPK innate immune hyperstimulation
itself does not lead to the induction small molecule detoxiﬁcation re-
sponses, and that other cellular mechanisms are engaged to recognize
and respond to xenobiotic toxins in C. elegans.
Endogenous hyperactivation of the p38 MAPK PMK-1
pathway protects nematodes from bacterial infection,
but is toxic to C. elegans
Stimulationof the p38MAPKpathwayby the smallmolecule xenobiotic
R24 protects C. elegans from bacterial infection by stimulating immune
effector expression through the p38 MAPK pathway (Pukkila-Worley
et al. 2012, 2014). Immune hyperactivation in this context has negative
physiological consequences to nematodes developing under normal
laboratory conditions (Figure 1). We therefore hypothesized that en-
dogenous hyperactivation of the p38 MAPK pathway, by means of a
gain-of-function mutation in the MAPKKK NSY-1, would display
similar phenotypes as worms treated with R24.
We tested the susceptibility of nsy-1(ums8) gain-of-function mu-
tant animals to P. aeruginosa infection compared to wild-type animals,
and found that nsy-1(ums8) animals were resistant to killing by
P. aeruginosa (Figure 4A and Figure S3). RNAi-mediated knockdown
of nsy-1 suppressed the resistance phenotype of nsy-1(ums8) animals
Figure 4 Endogenous hyperactivation of p38 MAPK innate immune
responses protects nematodes from bacterial infection and delays the
development of wild-type nematodes. In both (A) and (B), wild-type
animals were grown on RNAi bacteria expressing the empty vector L4440
(Wild-type), or a construct designed to knockdown nsy-1 [nsy-1(RNAi)].
nsy-1(ums8) animals, were grown in parallel on RNAi bacteria express-
ing the empty vector L4440 [nsy-1(ums8)], or a construct designed
to knockdown nsy-1 [nsy-1(ums8) + nsy-1(RNAi)]. (A) P. aeruginosa
pathogenesis assays were performed on RNAi-treated animals of the
indicated genotypes. The difference in P. aeruginosa susceptibility
between wild-type and nsy-1(ums8) animals is signiﬁcant, as is the
survival difference between nsy-1(ums8) and nsy-1(ums8) + nsy-1(RNAi)
(P , 0.001). Data are representative of two biological replicates. The
sample sizes for this experiment are: wild-type (115), nsy-1(RNAi) (122),
nsy-1(ums8) (111), and nsy-1(ums8) + nsy-1(RNAi) (133) (B) The devel-
opment of RNAi-treated animals of the indicated genotypes to the L4
larval stage or older was recorded. The data are the average of three
plates, with error bars showing the standard deviation between plates.
The sample sizes for this experiment are: wild-type + L4440 (1,200),
wild-type + nsy-1(RNAi) (1179), nsy-1(ums8) + L4440 (956), and
nsy-1(ums8) + nsy-1(RNAi) (1010). Data are representative of two
biological replicates.  P , 0.001.
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(Figure 4A). Interestingly, the development of nsy-1(ums8) larvae was
markedly delayed compared to wild-type controls, which was quan-
tiﬁed by determining the number of mutant and wild-type animals
that reached the L4 stage from synchronized eggs after 3 d of incu-
bation at 20 (Figure 4B). Knockdown of nsy-1 in nsy-1(ums8) ani-
mals partially suppressed this phenotype (Figure 2B and Figure 4B).
We also observed that nsy-1(ums8) animals had markedly smaller
brood sizes than wild-type controls (Figure S2B), data that are remi-
niscent of our observations with the immunostimulatory xenobiotic
R24 (Pukkila-Worley et al. 2012). In addition, RNAi-mediated knock-
down of pmk-1 also suppressed the delayed development of nsy-1(ums8)
animals (Figure S2C).
In this study, we provide direct evidence from two forward genetic
screens that aberrant stimulation of p38 MAPK PMK-1-mediated
innate immune responses via a gain-of-function mutation in nsy-1
or the exogenous addition of the anti-infective R24 drives immune
responses that are protective during infection, but are toxic to nem-
atodes under normal growth conditions. It is interesting to note that
the alleles with the most penetrant Xts phenotypes all had hypo-
morphic mutations in the known components of the p38 MAPK
pathway. Of note, a forward genetic screen for p38 MAPK pathway
components also did not identify mutations in any gene that func-
tions upstream of tir-1 (Shivers et al. 2010). Together, these data
suggest that the p38 MAPK signaling cassette receives multiple
inputs to regulate protective host responses in C. elegans.
In addition to promoting clearance of invading pathogens, an
emerging body of literature has established that host systems also
function to promote tolerance to infection, thereby reducing the
negative impact that infection can have on organismal ﬁtness (Ayres
and Schneider 2008; 2009). Conceptually, host tolerance mecha-
nisms function to mitigate the damage caused by the pathogen
and also limit collateral injury associated with immune activation
(Ayres and Schneider 2012; Medzhitov et al. 2012). Our studies of
the immunostimulatory xenobiotic R24 and the nsy-1(ums8) gain-
of-function allele suggest that host tolerance mechanisms may func-
tion in nematodes to limit the immunopathology associated with
aberrant p38 MAPK activation and the ensuing hyperproduction of
immune effectors. In C. elegans, the unfolded protein response
(UPR) is one such mechanism that has been shown to promote
tolerance during immune activation (Richardson et al. 2010; Sun
et al. 2011). The IRE1-XBP1/Hac1 branch of the UPR is required to
handle the physiological stress associated with an increase in p38
MAPK PMK-1 activity, which was conferred experimentally by ex-
posure to P. aeruginosa or through RNAi-mediated knockdown of
the MAPK phosphatase vhp-1, a negative regulator of PMK-1
(Richardson et al. 2010; Mizuno et al. 2004; Kim et al. 2004). Con-
sistent with these data, we found that xbp-1(zc12) mutants are dra-
matically susceptible to the toxic effects of the immunostimulatory
xenobiotic R24 in a developmental assay compared to control
animals (Figure S4). Thus, there are likely at least two mechanisms
in C. elegans to ensure immune homeostasis and promote toler-
ance during infection. The UPR functions to protect the host from
the ER stress, which occurs as a consequence of p38 MAPK acti-
vation (Richardson et al. 2010). In addition, the isolation of a
gain-of-function allele in nsy-1 argues that p38 MAPK PMK-1-
mediated transcriptional responses are controlled via upstream
mechanisms that negatively regulate immune activation at the
level of NSY-1.
The human homolog of NSY-1, ASK1, regulates p38 activity
through at least three conserved protein domains: a central serine-
threonine kinase domain and two coiled-coil domains in the N
and C termini, respectively (Figure 2A) (Bunkoczi et al. 2007). The
N-terminal domain binds thioredoxin (TRX), which inhibits the
function of NSY-1. Interestingly, the gain-of-function ums8 muta-
tion, in which the negatively charged Arg is substituted for Gln, an
uncharged amino acid with a large polar side chain, is located in a
strongly conserved region, eight amino acids upstream of the region
in NSY-1 predicted by homology to encode this N-terminal regula-
tory domain (Figure 2A). We hypothesize that the activity of
C. elegans NSY-1 is normally controlled by a negative regulatory
factor, which binds to the N-terminal coiled-coil domain. Thus, dis-
ruption of this region by the ums8 mutation could account for the
constitutive activation of p38 MAPK immune effectors resulting in a
pathogen resistance phenotype and toxicity to developing nematodes.
There are ﬁve thioredoxin (TRX) homologs in C. elegans and it will be
interesting to determine if any of these genes function as negative
regulators of NSY-1.
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